A preliminary report assessing the feasibility and effectiveness of amniotic bladder therapy in patients with chronic radiation cystitis
Codrut Radoiu1, Julian Jeberaeel1, Raghav Madan1, Nitin Vaishampayan1,2, Steve Lucas1,3, Alaa Hamada3, Nivedita Dhar3,4
Canadian Journal of Urology, Vol.30, No.4, pp. 11607-11612, 2023
Abstract Introduction: Chronic radiation cystitis (CRC) can develop between 6 months and 20 years after radiation therapy that presents with symptoms of urinary frequency, urgency, bladder pain, and nocturia. Amniotic membrane (AM) is known to contain pro-regenerative properties and could thereby be a potential therapeutic modality for radiation-induced tissue injury of the bladder.
Materials and methods: CRC patients recalcitrant to previous treatments received amniotic bladder therapy (ABT) comprised of intra-detrusor injections of 100 mg micronized AM (Clarix Flo) diluted in 10 mL 0.9% preservative-free sodium chloride. Clinical evaluation and questionnaires (Interstitial Cystitis Symptom Index (ICSI), Interstitial Cystitis Problem… More >